1. Armer RE, Barlow JS, Dutton CJ, Greenway DH, Greenwood SD, Lad N, Thompson AP, Thong KW, Tommasini I.. (1998) 8-Aminoquinolines as anticoccidials--II., 8 (12): [PMID:9873375] [10.1016/s0960-894x(98)00243-1] |
2. Bochis RJ, Chabala JC, Harris E, Peterson LH, Barash L, Beattie T, Brown JE, Graham DW, Waksmunski FS, Tischler M.. (1991) Benzylated 1,2,3-triazoles as anticoccidiostats., 34 (9): [PMID:1895303] [10.1021/jm00113a024] |
3. Biftu T, Feng D, Ponpipom M, Girotra N, Liang GB, Qian X, Bugianesi R, Simeone J, Chang L, Gurnett A, Liberator P, Dulski P, Leavitt PS, Crumley T, Misura A, Murphy T, Rattray S, Samaras S, Tamas T, Mathew J, Brown C, Thompson D, Schmatz D, Fisher M, Wyvratt M.. (2005) Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents., 15 (13): [PMID:15922595] [10.1016/j.bmcl.2005.04.060] |
4. Lagas JS, Sparidans RW, van Waterschoot RA, Wagenaar E, Beijnen JH, Schinkel AH.. (2008) P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin., 52 (3): [PMID:18195061] [10.1128/aac.01041-07] |
5. Jasenosky LD, Neumann G, Kawaoka Y.. (2010) Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription., 54 (7): [PMID:20421407] [10.1128/aac.00138-10] |
6. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
7. Huczyński A, Janczak J, Stefańska J, Antoszczak M, Brzezinski B.. (2012) Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin., 22 (14): [PMID:22721714] [10.1016/j.bmcl.2012.05.081] |
8. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
9. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040] |
10. Huczyński A.. (2012) Polyether ionophores-promising bioactive molecules for cancer therapy., 22 (23): [PMID:23063400] [10.1016/j.bmcl.2012.09.046] |
11. Huczyński A, Janczak J, Antoszczak M, Wietrzyk J, Maj E, Brzezinski B.. (2012) Antiproliferative activity of salinomycin and its derivatives., 22 (23): [PMID:23079523] [10.1016/j.bmcl.2012.09.068] |
12. Antoszczak M, Maj E, Stefańska J, Wietrzyk J, Janczak J, Brzezinski B, Huczyński A.. (2014) Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin., 24 (7): [PMID:24631190] [10.1016/j.bmcl.2014.02.042] |
13. Stefańska J, Antoszczak M, Stępień K, Bartoszcze M, Mirski T, Huczyński A.. (2015) Tertiary amides of Salinomycin: A new group of antibacterial agents against Bacillus anthracis and methicillin-resistant Staphylococcus epidermidis., 25 (10): [PMID:25891104] [10.1016/j.bmcl.2015.03.085] |
14. Huczyński A, Antoszczak M, Kleczewska N, Lewandowska M, Maj E, Stefańska J, Wietrzyk J, Janczak J, Celewicz L.. (2015) Synthesis and biological activity of salinomycin conjugates with floxuridine., 93 [PMID:25644674] [10.1016/j.ejmech.2015.01.045] |
15. Bhat MA, Al-Dhfyan A, Khan AA, Al-Harbi N, Manogaran PS, Alanazi AM, Fun HK, Al-Omar MA.. (2014) Targeting HER-2 over expressed breast cancer cells with 2-cyclohexyl-N-[(Z)-(substituted phenyl/furan-2-yl/thiophene-2-yl)methylidene]hydrazinecarbothioamide., 25 (1): [PMID:25466196] [10.1016/j.bmcl.2014.11.009] |
16. Antoszczak M, Sobusiak M, Maj E, Wietrzyk J, Huczyński A.. (2015) Synthesis and antiproliferative activity of new bioconjugates of Salinomycin with amino acid esters., 25 (17): [PMID:26163197] [10.1016/j.bmcl.2015.06.086] |
17. Borgström B, Huang X, Chygorin E, Oredsson S, Strand D.. (2016) Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids., 7 (6): [PMID:27326340] [10.1021/acsmedchemlett.6b00079] |
18. Huang M, Deng Z, Tian J, Liu T.. (2017) Synthesis and biological evaluation of salinomycin triazole analogues as anticancer agents., 127 [PMID:27876192] [10.1016/j.ejmech.2016.10.067] |
19. Li B, Wu J, Zhang W, Li Z, Chen G, Zhou Q, Wu S.. (2017) Synthesis and biological activity of salinomycin-hydroxamic acid conjugates., 27 (7): [PMID:28262526] [10.1016/j.bmcl.2017.01.080] |
20. Ogunsina M, Samadder P, Idowu T, Arthur G, Schweizer F.. (2017) Replacing d-Glucosamine with Its l-Enantiomer in Glycosylated Antitumor Ether Lipids (GAELs) Retains Cytotoxic Effects against Epithelial Cancer Cells and Cancer Stem Cells., 60 (5): [PMID:28177244] [10.1021/acs.jmedchem.6b01773] |
21. Idowu T, Samadder P, Arthur G, Schweizer F.. (2017) Amphiphilic Modulation of Glycosylated Antitumor Ether Lipids Results in a Potent Triamino Scaffold against Epithelial Cancer Cell Lines and BT474 Cancer Stem Cells., 60 (23): [PMID:29043812] [10.1021/acs.jmedchem.7b01198] |
22. (2016) 7 (11): [10.1039/C6MD00328A] |
23. Zhang W, Wu J, Li B, Lian X, Xia J, Zhou Q, Wu S.. (2017) Design and synthesis of conformationally constrained salinomycin derivatives., 138 [PMID:28688275] [10.1016/j.ejmech.2017.06.063] |
24. Li Y, Shi Q, Shao J, Yuan Y, Yang Z, Chen S, Zhou X, Wen S, Jiang ZX.. (2018) Synthesis and biological evaluation of 20-epi-amino-20-deoxysalinomycin derivatives., 148 [PMID:29466777] [10.1016/j.ejmech.2018.02.004] |
25. Markowska A, Sajdak S, Markowska J, Huczyński A.. (2017) Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer., 142 [PMID:28651817] [10.1016/j.ejmech.2017.06.030] |
26. Antoszczak M, Urbaniak A, Delgado M, Maj E, Borgström B, Wietrzyk J, Huczyński A, Yuan Y, Chambers TC, Strand D.. (2018) Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo., 156 [PMID:30025346] [10.1016/j.ejmech.2018.07.021] |
27. Sangeun Jeon, Meehyun Ko, Jihye Lee, Inhee Choi, Soo Young Byun, Soonju Park, David Shum, Seungtaek Kim. (2020) Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs, [10.1101/2020.03.20.999730] |
28. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
29. Antoszczak M.. (2019) A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents., 166 [PMID:30684870] [10.1016/j.ejmech.2019.01.034] |
30. Nalli Y, Dar MS, Bano N, Rasool JU, Sarkar AR, Banday J, Bhat AQ, Rafia B, Vishwakarma RA, Dar MJ, Ali A.. (2019) Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain., 29 (9): [PMID:30871771] [10.1016/j.bmcl.2019.03.013] |
31. Antoszczak M, Steverding D, Sulik M, Janczak J, Huczyński A.. (2019) Anti-trypanosomal activity of doubly modified salinomycin derivatives., 173 [PMID:30986574] [10.1016/j.ejmech.2019.03.061] |
32. Antoszczak M, Huczyński A.. (2019) Salinomycin and its derivatives - A new class of multiple-targeted "magic bullets"., 176 [PMID:31103901] [10.1016/j.ejmech.2019.05.031] |
33. Antoszczak M, Steverding D, Huczyński A.. (2019) Anti-parasitic activity of polyether ionophores., 166 [PMID:30684869] [10.1016/j.ejmech.2019.01.035] |
34. Sulik M, Stępień K, Stefańska J, Huczyński A, Antoszczak M.. (2020) Antibacterial activity of singly and doubly modified salinomycin derivatives., 30 (9): [PMID:32147358] [10.1016/j.bmcl.2020.127062] |
35. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
36. Czerwonka D,Barcelos Y,Steverding D,Cioch A,Huczyński A,Antoszczak M. (2021) Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei., 209 [PMID:33071053] [10.1016/j.ejmech.2020.112900] |
37. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
38. Liao M, Zhang J, Wang G, Wang L, Liu J, Ouyang L, Liu B.. (2021) Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions., 64 (5.0): [PMID:33650861] [10.1021/acs.jmedchem.0c01180] |
39. Yin L, Liu P, Jin Y, Ning Z, Yang Y, Gao H.. (2022) Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications., 244 [PMID:36332549] [10.1016/j.ejmech.2022.114861] |